No connection

Search Results

BWAY vs IVVD

BWAY
BrainsWay Ltd.
NEUTRAL
Price
$12.26
Market Cap
$490.8M
Sector
Healthcare
AI Confidence
60%
IVVD
Invivyd, Inc.
BEARISH
Price
$1.76
Market Cap
$497.7M
Sector
Healthcare
AI Confidence
90%

Valuation

P/E Ratio
BWAY
68.11
IVVD
--
Forward P/E
BWAY
27.45
IVVD
-8.0
P/B Ratio
BWAY
6.14
IVVD
2.05
P/S Ratio
BWAY
9.4
IVVD
9.31
EV/EBITDA
BWAY
68.3
IVVD
-4.98

Profitability

Gross Margin
BWAY
75.42%
IVVD
92.99%
Operating Margin
BWAY
13.17%
IVVD
-72.96%
Profit Margin
BWAY
14.62%
IVVD
-98.25%
ROE
BWAY
11.26%
IVVD
-33.97%
ROA
BWAY
2.61%
IVVD
-17.09%

Growth

Revenue Growth
BWAY
27.4%
IVVD
24.5%
Earnings Growth
BWAY
390.8%
IVVD
--

Financial Health

Debt/Equity
BWAY
0.09
IVVD
0.01
Current Ratio
BWAY
3.83
IVVD
7.24
Quick Ratio
BWAY
3.24
IVVD
7.06

Dividends

Dividend Yield
BWAY
--
IVVD
--
Payout Ratio
BWAY
0.0%
IVVD
0.0%

AI Verdict

BWAY NEUTRAL

BWAY shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 8/9). Key strengths include strong valuation and growth metrics. Price trades at a 130.9% premium to fair value estimate ($5.31), limiting near-term upside from a valuation perspective.

Strengths
Strong financial trend (Piotroski F-Score: 8/9)
Strong revenue growth of 27.4%
Low debt with D/E ratio of 0.09
Risks
High valuation with P/E of 68.1
Premium vs Graham Number ($2.84)
Price trades at a 130.9% premium to fair value estimate ($5.31), limiting near-term upside from a valuation perspective.
IVVD BEARISH

Invivyd exhibits critical financial weakness, highlighted by a Piotroski F-Score of 0/9, indicating a complete lack of fundamental improvement across all measured categories. While the company maintains a strong liquidity position with a Current Ratio of 7.24 and very low debt, it is suffering from extreme operational inefficiency with a profit margin of -98.25%. There is a stark disconnect between the analyst 'Strong Buy' consensus (Target $10.00) and the deterministic data, which shows consistent earnings misses and bearish insider activity.

Strengths
High Gross Margin (92.99%) suggesting strong product pricing potential
Strong short-term liquidity with a Current Ratio of 7.24
Very low leverage with a Debt/Equity ratio of 0.01
Risks
Severe operational losses with a profit margin of -98.25%
Deterministic health failure (Piotroski F-Score 0/9)
Consistent failure to meet earnings estimates (1/4 beats in last 4 quarters)

Compare Another Pair

BWAY vs IVVD: Head-to-Head Comparison

This page compares BrainsWay Ltd. (BWAY) and Invivyd, Inc. (IVVD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile